Literature DB >> 20850989

Uncalibrated arterial pulse cardiac output measurements in patients with moderately abnormal left ventricular function.

Luigi Vetrugno1, Maria Gabriella Costa, Lorenzo Spagnesi, Livia Pompei, Paolo Chiarandini, Isabella Gimigliano, Giorgio Della Rocca.   

Abstract

OBJECTIVE: The aim of the study was to evaluate the accuracy and precision of the Vigileo/FloTrac system (Edwards Lifesciences, Irvine, CA) when compared with the intermittent cardiac output and continuous cardiac output measurements obtained from pulmonary arterial catheters in patients with moderately abnormal left ventricular function undergoing elective coronary artery bypass graft surgery.
DESIGN: A prospective, observational study.
SETTING: Tertiary university hospital. PARTICIPANTS: Twenty patients with moderately abnormal left ventricular function undergoing coronary artery bypass graft surgery were enrolled. MEASUREMENTS AND
RESULTS: Data were collected before the induction of anesthesia (T1), after the induction of anesthesia (T2), before cardiopulmonary bypass with an open chest (T3), after cardiopulmonary bypass (T4), after sternal closure (T5), on intensive care unit admission (T6), and at 6 hours (T7) and 12 hours after surgery (T8). A total of 360 data measurements were collected; the mean bias between intermittent cardiac output (ICO) and arterial pressure cardiac output (APCO) was -0.50 ± 1.72 L/min, and the percentage error (PE) was 37.00%. The mean difference between CCO and APCO was -0.06 ± 1.84 L/min, and the PE was 37.80%. The correlation between ΔICO and ΔAPCO was r = 0.7; the correlation between ΔCCO and ΔAPCO was r = 0.73. In the intraoperative period, the mean bias between ICO and APCO was -0.41 ± 1.75 L/min, and the PE was 40.87%. The mean difference between CCO and APCO was -0.18 ± 1.90 L/min, and the PE was 41.48%. In the postoperative period, the mean bias between ICO and APCO was -0.56 ± 1.70 L/min, and the PE was 34.43%. The mean difference between CCO and APCO was -0.36 ± 1.76 L/min, and the PE was 34.87%.
CONCLUSIONS: In cardiac surgical patients with moderately abnormal left ventricular function, the Vigileo/FloTrac 2nd generation software sensor device showed mild intraoperative and postoperative agreement when compared with a pulmonary arterial catheter.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20850989     DOI: 10.1053/j.jvca.2010.07.001

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  5 in total

1.  Noninvasive pulse contour analysis for determination of cardiac output in patients with chronic heart failure.

Authors:  Sebastian Roth; Henrik Fox; Uwe Fuchs; Uwe Schulz; Angelika Costard-Jäckle; Jan F Gummert; Dieter Horstkotte; Olaf Oldenburg; Thomas Bitter
Journal:  Clin Res Cardiol       Date:  2018-01-19       Impact factor: 5.460

2.  The ability of a new continuous cardiac output monitor to measure trends in cardiac output following implementation of a patient information calibration and an automated exclusion algorithm.

Authors:  Hironori Ishihara; Yoshihiro Sugo; Masato Tsutsui; Takashige Yamada; Tetsufumi Sato; Toshimasa Akazawa; Nobukazu Sato; Koichi Yamashita; Junzo Takeda
Journal:  J Clin Monit Comput       Date:  2012-08-02       Impact factor: 2.502

3.  Reliability of cardiac output measurements using LiDCOrapid™ and FloTrac/Vigileo™ across broad ranges of cardiac output values.

Authors:  Masaaki Asamoto; Ryo Orii; Mikiya Otsuji; Masahiko Bougaki; Yousuke Imai; Yoshitsugu Yamada
Journal:  J Clin Monit Comput       Date:  2016-06-14       Impact factor: 2.502

4.  The use of an external ultrasound fixator (Probefix) on intensive care patients: a feasibility study.

Authors:  M J Blans; F H Bosch; J G van der Hoeven
Journal:  Ultrasound J       Date:  2019-10-11

5.  Liberal or restricted fluid administration: are we ready for a proposal of a restricted intraoperative approach?

Authors:  Giorgio Della Rocca; Luigi Vetrugno; Gabriella Tripi; Cristian Deana; Federico Barbariol; Livia Pompei
Journal:  BMC Anesthesiol       Date:  2014-08-01       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.